Towards a nanoscale mammographic contrast agent: Development of a modular pre-clinical dual optical/x-ray agent

Physics in Medicine and Biology

Volumn 58, Issue 15, 2013, Pages 5215-5235

  Hill, Melissa L ^a,b   Gorelikov, Ivan ^a   Niroui, Farnaz ^a   Levitin, Ronald B ^a   Mainprize, James G ^a   Yaffe, Martin J ^a,b   Rowlands, J A ^a,b,c   Matsuura, Naomi ^a,b  

^a Canada   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Thunder Bay Regional Research Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER DETECTION; CONTRAST-ENHANCED; DIGITAL MAMMOGRAPHY; FLUORESCENT QUANTUM DOTS; INTERSTITIAL SPACE; MAMMOGRAPHIC ENERGY; OPTICAL FLUORESCENCE; QUANTITATIVE ASSESSMENTS;

BIOCOMPATIBILITY; FLUORESCENCE; MAMMOGRAPHY; MEDICAL IMAGING; NANOTECHNOLOGY; OPTICAL CORRELATION; OPTIMIZATION; TUMORS; X RAY ANALYSIS;

DROPS;

CONTRAST MEDIUM; FLUOROCARBON; NANOMATERIAL; PERFLUOROOCTYL BROMIDE; DIAGNOSTIC AGENT;

ANIMAL; CELL LINE; CHEMISTRY; DIAGNOSTIC USE; IMAGE QUALITY; LIGHT RELATED PHENOMENA; MAMMOGRAPHY; MOUSE; PROCEDURES; X RAY; ARTICLE; METHODOLOGY;

ANIMALS; CELL LINE; CONTRAST MEDIA; FLUOROCARBONS; MAMMOGRAPHY; MICE; NANOSTRUCTURES; OPTICAL PROCESSES; PHANTOMS, IMAGING; X-RAYS;

EID: 84880575564     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/58/15/5215     Document Type: Article

References (50)

1. Babiak P, Nemcova A, Rulisek L and Beier P 2008 On the miscibility of ethers and perfluorocarbons an experimental and theoretical study J. Fluorine Chem. 129 397-401
2. Barlow W E et al 2002 Performance of diagnostic mammography for women with signs or symptoms of breast cancer J. Natl Cancer Inst. 94 1151-9 (www.ncbi.nlm.nih.gov/pubmed/12165640)
3. Behan M, O'Connell D, Mattrey R F and Carney D N 1993 Perfluorooctylbromide as a contrast agent for CT and sonography: preliminary clinical results Am. J. Roentgenol. 160 399-405 (www.ncbi.nlm.nih.gov/pubmed/ 8424361)
4. Benders K E M, Malda J, Saris D B F, Dhert W J A, Steck R, Hutmacher D W and Klein T J 2010 Formalin fixation affects equilibrium partitioning of an ionic contrast agent-microcomputed tomography (EPIC-μCT) imaging of osteochondral samples Osteoarthritis Cartilage 18 1586-91 (www.ncbi.nlm.nih.gov/ pubmed/20950691)
5. Boone J M, Fewell T R and Jennings R J 1997 Molybdenum, rhodium, and tungsten anode spectral models using interpolating polynomials with application to mammography Med. Phys. 24 1863-74 (www.ncbi.nlm.nih.gov/pubmed/9434969)
6. Bourin M, Jolliet P and Ballereau F 1997 An overview of the clinical pharmacokinetics of x-ray contrast media Clin. Pharmacokinet. 32 180-93
7. Bruneton J-N, Falewee M-N, Francois E, Cambon P, Philip C, Riess J G, Balu-Maestro C and Rogopoulos A 1989 Liver, spleen, and vessels: preliminary clinical-results of CT with perfluorooctylbromide Radiology 170 179-83
8. Carney P A et al 2003 Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography Ann. Intern. Med. 138 168-75 (www.ncbi.nlm.nih.gov/pubmed/12558355)
9. Carton A-K, Li J, Albert M, Chen S and Maidment A D A 2006 Quantification for contrast-enhanced digital breast tomosynthesis Proc. SPIE 6142 61420D
10. Castro C I and Briceno J C 2010 Perfluorocarbon-based oxygen carriers: review of products and trials Artif. Organs 34 622-34 (www.ncbi.nlm.nih.gov/ pubmed/20698841)
11. Chen R C et al 2010 Measurement of the linear attenuation coefficients of breast tissues by synchrotron radiation computed tomography Phys. Med. Biol. 55 4993-5005 (www.ncbi.nlm.nih.gov/pubmed/20702925)
12. Danquah M K, Zhang X A and Mahato R I 2011 Extravasation of polymeric nanomedicines across tumor vasculature Adv. Drug Deliv. Rev. 63 623-39 (www.ncbi.nlm.nih.gov/pubmed/21144874)
13. Diekmann F, Diekmann S, Jeunehomme F, Muller S, Hamm B and Bick U 2005 Digital mammography using iodine-based contrast media: initial clinical experience with dynamic contrast medium enhancement Invest. Radiol. 40 397-404
14. Diekmann F, Sommer A, Diekmann S, Pietsch H, Hamm B and Bick U 2007 Contrast-to-noise ratios of different elements in digital mammography - evaluation of their potential as new contrast agents Invest. Radiol. 42 319-25
15. Ding J et al 2013 CT/fluorescence dual-modal nanoemulsion platform for investigating atherosclerotic plaques Biomaterials 34 209-16 (www.ncbi.nlm.nih.gov/pubmed/23069709)
16. Dobrovolskaia M A, Aggarwal P, Hall J B and McNeil S E 2008 Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution Mol. Pharm. 5 487-95
17. Dromain C, Balleyguier C, Muller S, Mathieu M-C, Rochard F, Opolon P and Sigal R 2006 Evaluation of tumor angiogenesis of breast carcinoma using contrast-enhanced digital mammography Am. J. Roentgenol. 187 528-37
18. Dromain C, Thibault F, Diekmann F, Fallenberg E M, Jong R A, Koomen M, Hendrick R E, Tardivon A and Toledano A 2012 Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase study Breast Cancer Res. 14 R94 (www.ncbi.nlm.nih.gov/pubmed/22697607)
19. Dromain C, Thibault F, Muller S, Rimareix F, Delaloge S, Tardivon A and Balleyguier C 2011 Dual-energy contrast-enhanced digital mammography: initial clinical results Eur. Radiol. 21 565-74 (www.ncbi.nlm.nih.gov/pubmed/20839001)
20. Froeling V, Diekmann F, Renz D M, Fallenberg E M, Steffen I G, Diekmann S, Lawaczeck R and Schmitzberger F F 2013 Correlation of contrast agent kinetics between iodinated contrast-enhanced spectral tomosynthesis and gadolinium-enhanced MRI of breast lesions Eur. Radiol. 23 1528-36 (www.ncbi.nlm.nih.gov/pubmed/23306708)
21. Galper M W, Saung M T, Fuster V, Roessl E, Thran A, Proksa R, Fayad Z A and Cormode D P 2012 Effect of computed tomography scanning parameters on gold nanoparticle and iodine contrast Invest. Radiol. 47 475-81 (www.ncbi.nlm.nih. gov/pubmed/22766909)
22. Gorelikov I, Martin A L, Seo M and Matsuura N 2011 Silica-coated quantum dots for optical evaluation of perfluorocarbon droplet interactions with cells Langmuir 27 15024-33 (www.ncbi.nlm.nih.gov/pubmed/22026433)
23. Gorelikov I and Matsuura N 2008 Single-step coating of mesoporous silica on cetyltrimethyl ammonium bromide-capped nanoparticles Nano Lett. 8 369-73 (www.ncbi.nlm.nih.gov/pubmed/18072800)
24. Hashizume H, Baluk P, Morikawa S, McLean J W, Thurston G, Roberge S, Jain R K and McDonald D M 2000 Openings between defective endothelial cells explain tumor vessel leakiness Am. J. Pathol. 156 1363-80 (http://amjpathol.highwire. org/cgi/content/full/156/4/1363)
25. Huang S-Y, Boone J M, Yang K, Packard N J, McKenney S E, Prionas N D, Lindfors K K and Yaffe M J 2011 The characterization of breast anatomical metrics using dedicated breast CT Med. Phys. 38 2180-91
26. Hubbell J H and Seltzer S M 2004 Tables of x-ray mass attenuation coefficients and mass energy-absorption coefficients (version 1.4) (Gaithersburg, MD: National Institute of Standards and Technology) (http://physics.nist.gov/xaamdi)
27. Jain R K and Stylianopoulos T 2010 Delivering nanomedicine to solid tumors Nature Rev. Clin. Oncol. 7 653-64
28. Jochelson M S, Dershaw D D, Sung J S, Heerdt A S, Thornton C, Moskowitz C S, Ferrara J and Morris E A 2013 Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma Radiology 266 743-51 (http://radiology.rsna.org.myaccess.library.utoronto.ca/content/early/ 2012/11/30/radiol.12121084.full)
29. Johns P C and Yaffe M J 1987 X-ray characterisation of normal and neoplastic breast tissues Phys. Med. Biol. 32 675-95 (www.iop.org/EJ/article/ 0031 - 9155/32/6/002/pbv32i6p675.pdf)
30. Jones A K and Mahvash A 2012 Evaluation of the potential utility of flat panel CT for quantifying relative contrast enhancement Med. Phys. 39 4149-54
31. Jong R A, Yaffe M J, Skarpathiotakis M, Shumak R S, Danjoux N M and Gunesekara A 2003 Contrast-enhanced digital mammography: initial clinical experience Radiology 228 842-50
32. Krafft M P and Reiss J G 2007 Perfluorocarbons: life sciences and biomedical uses - dedicated to the memory of professor Guy Ourisson, a true RENAISSANCE man J. Polym. Sci. A 45 1185-98
33. Lawaczeck R, Diekmann F, Diekmann S, Hamm B, Bick U, Press W-R, Schirmer H, Schön K and Weinmann H-J 2003 New contrast media designed for x-ray energy subtraction imaging in digital mammography Invest. Radiol. 38 602-8 (www.ncbi.nlm.nih.gov/pubmed/12960530)
34. Lewin J M, Isaacs P K, Vance V and Larke F J 2003 Dual-energy contrast-enhanced digital subtraction mammography: feasibility Radiology 229 261-8 (www.ncbi.nlm.nih.gov/pubmed/12888621)
35. Maeda H 2010 Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects Bioconjug. Chem. 21 797-802
36. Martin A L, Seo M, Williams R, Belayneh G, Foster F S and Matsuura N 2012 Intracellular growth of nanoscale perfluorocarbon droplets for enhanced size-dependent ultrasound conversion Ultrasound Med. Biol. 38 1799-820
37. Matsuura N, Gorelikov I, Williams R, Wan K, Zhu S, Booth J, Burns P, Hynynen K and Rowlands J A 2009 Nanoparticle-tagged perfluorocarbon droplets for medical imaging Advances in Material Design for Regenerative Medicine, Drug Delivery and Targeting/Imaging vol 1140 ed V P Shastri, A Lendlein, L Liu, A Mikos and S Mitragotri (Warrendale, PA: Materials Research Society) pp 87-92
38. Matsuura N and Rowlands J A 2008 Towards new functional nanostructures for medical imaging Med. Phys. 35 4474-87
39. Miles K A, Young H, Chica S L and Esser P D 2007 Quantitative contrast-enhanced computed tomography: is there a need for system calibration? Eur. Radiol. 17 919-26 (www.ncbi.nlm.nih.gov/pubmed/17008987)
40. Moghimi S M, Hunter A C and Murray J C 2001 Long-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 283-318 (www.ncbi.nlm.nih.gov/pubmed/11356986)
41. Moghimi S M, Hunter A C and Murray J C 2005 Nanomedicine: current status and future prospects FASEB J. 19 311-30
42. Morcos S K and Thomsen H 2001 Adverse reactions to iodinated contrast media Eur. Radiol. 11 1267-75
43. Nobbmann U et al 2007 Dynamic light scattering as a relative tool for assessing the molecular integrity and stability of monoclonal antibodies Biotechnol. Genet. Eng. Rev. 24 117-28
44. Ntziachristos V, Ripoll J, Wang L V and Weissleder R 2005 Looking and listening to light: the evolution of whole-body photonic imaging Nature Biotechnol. 23 313-20
45. Pisano E D et al 2005 Diagnostic performance of digital versus film mammography for breast-cancer screening N. Engl. J. Med. 353 1773-83 (http://content.nejm.org/cgi/content/abstract/353/17/1773)
46. Reiss J G 2001 Oxygen carriers ('blood substitutes')-Raison d'Etre, chemistry, and some physiology Chem. Rev. 201 2797-919
47. Suryanarayanan S, Sechopoulos I, Vedantham S and Karellas A 2007 Feasibility of low dose x-ray contrast enhanced digital mammography with gold nanoparticles Med. Phys. 34 2360
48. Thibault F, Balleyguier C, Tardivon A and Dromain C 2012 Contrast enhanced spectral mammography: better than MRI? Eur. J. Radiol. 81 S162-4 (http://linkinghub.elsevier.com/retrieve/pii/S0720048×12700682)
49. Yi D K, Selvan S T, Lee S S, Papaefthymiou G C, Kundaliya D and Ying J Y 2005 Silica-coated nanocomposites of magnetic nanoparticles and quantum dots J. Am. Chem. Soc. 127 4990-1
50. Yu W W, Qu L, Guo W and Peng X 2003 Experimental determination of the extinction coefficient of CdTe, CdSe, and CdS nanocrystals Chem. Mater. 15 2854-60